Storys aus Lausanne
-
Sprache:
Englisch
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- mehr
DEBIOPHARM'S NEW GENERATION RADIONUCLIDE THERAPY ADVANCES INTO CLINICAL RESEARCH IN THE FIGHT AGAINST LUNG CANCER
Lausanne (ots) - First patient dosed in the phase I small cell lung cancer (SCLC) trial with Debio 1124, a molecular-targeted radiotherapy Debiopharm (www.debiopharm.com), a Swiss-based, global biopharmaceutical company, today announced the first patient dosed in the multicenter, single-arm, open-label Phase 1 study ...
mehrDEBIOPHARM'S IAP ANTAGONIST SIGNIFICANTLY IMPROVES OVERALL SURVIVAL OF HIGH-RISK HEAD & NECK CANCER PATIENTS
Lausanne, Switzerland (ots) - Promising overall survival outcomes at 3-years for high-risk, locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) patients observed with Debio 1143 + CRT Debiopharm (www.debiopharm.com), a Swiss-based, global biopharmaceutical company, today announced the release of ...
mehrSchweizerischer Nationalfonds / Fonds national suisse
28 new coronavirus research projects funded under NRP "COVID-19"
Bern (ots) - New research has been launched to better control COVID-19. 18.6 million francs have been invested in projects that will investigate innovative solutions and develop public health recommendations. Mandated by the Federal Council, the SNSF launched the National Research Programme "COVID-19" (NRP 78) on 30 April 2020 to advance our understanding of the ...
mehrNUCLEAI SECURED $6.5M SERIES-A INITIAL CLOSING LED BY DEBIOPHARM TO ADVANCE AI-POWERED PRECISION ONCOLOGY PLATFORM
Tel Aviv, Israel, Lausanne, Switzerland (ots) - - Nucleai, a computational biology company providing an AI-powered precision oncology platform for research and treatment decisions, secured $6.5M Series A initial closing. - Debiopharm's strategic corporate venture capital fund led the round joined by existing ...
mehrEuroclear Holding, Euroclear Investments, Euroclear SA/NV
Euroclear: Directorate Changes
Brussels (ots/PRNewswire) - The Euroclear group announces that Marc Antoine Autheman has decided to step down as the Chairman and Director of the Euroclear boards. During Mr Autheman's eight year tenure, Euroclear's strategy has resulted in its strong financial position and performance, delivering consistently growing returns for shareholders and value for its financial market participants, whilst adapting to meet the requirements of the post-financial crisis regulatory and ...
mehr
Galderma Global Research Reveals Struggles of People With Rosacea and Psoriasis of the Face Experiencing a Lack of Control and Impact on Mental Wellbeing
Lausanne, Switzerland (ots/PRNewswire) - Healthcare professionals (HCPs) encouraged to investigate true impacts beyond the visible, empower patients with knowledge and aim for 'clear' (IGA 0) skin to improve outcomes A new expert-authored Galderma report (https://hosted.bmj.com/rosaceabeyondthevisible) released ...
mehrDebiopharm's Novel Microbiome Remodeling Program Licensed to Takeda for the Treatment of Gastrointestinal Disorders
Lausanne, Switzerland (ots) - Takeda will pursue the development of a novel preclinical narrow spectrum microbiome remodeling program, to treat diseases related to dysbiosis of the human gut microbiome Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced today an exclusive license agreement ...
mehrAcquisition of Debiopharm's investment portfolio company Kaiku Health broadens patient access to digital oncology intervention
Lausanne, Switzerland (ots) - - Debiopharm announces successful exit deal for Kaiku Health, a Finnish start-up specializing in digital solutions for improved patient outcomes and experience - Kaiku's acquisition by the Swedish company Elekta allows thousands of cancer treatment centers to gain access to the ...
mehrSchweizerischer Nationalfonds / Fonds national suisse
The SNSF funds 36 new coronavirus research projects
Bern (ots) - Under the special call on coronaviruses, the societal and biomedical aspects of epidemics will be investigated with a total budget of 10 million francs. The projects will start as of 1 June 2020. As the coronavirus pandemic began to take hold, the SNSF took swift action by launching a special call on coronaviruses on 6 March 2020. The call was enthusiastically received in the research community. - ...
mehrSchweizerischer Nationalfonds / Fonds national suisse
Imaging science
Bern (ots) - Spectacular photographs, provocative videos and intimate stories shed new light on contemporary research. The jury for this year's SNSF Scientific Image Competition has awarded four first prizes and seven distinctions. The fourth SNSF Scientific Image Competition has been a great success. "These stunning images offer a view of science that is very different from the usual clichés of white coats, antiseptic laboratories and faceless researchers", says Nadine ...
mehrSOPHiA GENETICS Expands Its Executive Team, Naming Lara Hashimoto Chief Business Officer
Lausanne, Switzerland and Boston (ots/PRNewswire) - SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that Lara Hashimoto has joined its Executive Team as Chief Business Officer, effective April 1st. She will be responsible for Marketing, Product Management and Business Development. Lara Hashimoto joined the healthcare industry 20 years ago holding ...
mehr
SOPHiA GENETICS and Paragon Genomics Join Forces Against the COVID-19 Coronavirus Pandemic
Lausanne, Switzerland, and Boston (ots/PRNewswire) - SOPHiA GENETICS, leader in Data-Driven Medicine, today announced that it is entering the fight against the COVID-19 coronavirus by extending its partnership with Paragon Genomics, who developed a next-generation sequencing (NGS) assay and leveraging the SOPHiA Platform analytical capabilities, as well as delivering ...
mehrSOPHiA GENETICS' Board of Directors Elects Troy Cox as New Chairman
Lausanne, Switzerland and Boston (ots/PRNewswire) - SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that former Foundation Medicine CEO Troy Cox has been elected as Chairman of the Board of Directors, effective March 1, 2020. He is replacing Antoine Duchateau, who has served as chairman since 2013 and will continue as a board member. Cox joined the ...
mehrNovadiscovery raises series A financing to scale its in silico clinical trial platform - Debiopharm leads the round with EUR 5 million
Lausanne (ots) - - Novadiscovery pioneers the use of in silico clinical trials to predict drug efficacy and optimize clinical development, an approach meeting the strong expectations from pharmaceutical companies for faster and more efficient development, and benefiting from increased endorsement from health ...
mehrKnight Partners with Debiopharm for the Commercialization of Trelstar® in Canada
MONTREAL, CANADA and LAUSANNE, SWITZERLAND (ots) - Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company and Debiopharm, a swiss-based, global biopharmaceutical company, today announced that they have entered into an exclusive agreement that grants Knight the rights to commercialize Trelstar® (triptorelin) in Canada. ...
mehrSchweizerischer Nationalfonds / Fonds national suisse
The 2020 SNSF Scientific Image Competition is underway
Bern (ots) - Capturing the beauty of science: the Swiss National Science Foundation is once again holding its photo and short video competition in 2020. Nadine Wietlisbach, director of the Fotomuseum Winterthur, will chair the jury. The images will be exhibited for the first time at the Biel/Bienne Photography Festival in May and will be freely available to the public and the media. The 2020 edition of the SNSF Scientific ...
mehrFace Up To Rosacea: Galderma Launches Online Support to Empower and Equip Rosacea Sufferers to Discuss the True Burden of Their Disease With a Dermatologist
New 'Face up to rosacea' campaign comprising online content and a downloadable, personalized patient appointment guide, equips people living with the distressing skin disease to seek expert support to help break the cycle of rosacea and aim for long-term treatment success Lausanne, Switzerland (ots/PRNewswire) - ...
mehr
Changemakers from over 46 countries met in Zermatt / 8th Zermatt Summit 2019 - Humanizing Globalization - Entrepreneurship to serve the common good
mehrA pancreatic and colorectal cancer trial initiated to address the needs of patients with Immune Checkpoint Inhibitor-resistant disease by combining IAP antagonist Debio 1143 with Keytruda®
Lausanne (ots) - First patient enrolled in the investigator initiated CATRIPCA study (Combination with an IAP Antagonist To Reverse Immune resistance in Pancreatic and Colorectal Adenocarcinoma) at the Léon Bérard Cancer Center in Lyon France Debiopharm (www.debiopharm.com) announced today the first patient ...
mehrSOPHiA GENETICS Expands Executive Team With a Chief Marketing Officer and New Chief Information Officer
Lausanne, Switzerland, and Boston (ots/PRNewswire) - SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that Gaëtan Fraikin and Sergei Yakneen have joined its executive team as Chief Marketing Officer and Chief Information Officer, respectively. Mr. Fraikin and Mr. Yakneen bring decades of highly ...
mehrNewly Published ROSacea COnsensus (ROSCO) Expert Recommendations Encourage Dermatologists to Upweight Burden-related Discussions, Aim For 'Complete Clearance' of Symptoms and Consider Combination Therapy For Severe Patients
Experts also welcome upsurge in the adoption of a rosacea signs and symptoms ('phenotype') led approach in clinical practice and announce the launch of prototype clinical tools to support physicians to optimize rosacea management Lausanne, Switzerland (ots/PRNewswire) - Published online in the British Journal of ...
mehrDebiopharm successfully completes randomized Phase II study for IAP antagonist Debio 1143 in high risk head & neck cancer patients
Lausanne, Switzerland (ots) - Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, announced positive topline results across clinical endpoints following the completion of the two-year follow-up period of its double-blind, randomized Phase II study of Debio 1143 in high-risk, previously untreated ...
mehrSchweizerischer Nationalfonds / Fonds national suisse
Sex education: Why school and parents should work together
Bern (ots) - There is an ongoing debate in society about sex education. Now a study funded by the Swiss National Science Foundation suggests that the best approach is a combination of parents and school. And that using friends and the internet as main sources of information on sexuality can cause problems. Sex education in school remains a controversial subject. That's why Yara Barrense-Dias, researcher on adolescent ...
mehr
ADC Therapeutics and SOPHiA GENETICS Partner for Biomarker Discovery in Pivotal Phase II Clinical Trial
Study to identify genomic markers associated with clinical response to ADCT-402 (loncastuximab tesirine) in relapsed or refractory diffuse large B-cell lymphoma (DLBCL) Lausanne, Switzerland (ots/PRNewswire) - ADC Therapeutics, an oncology drug discovery and development company that specializes in the development ...
mehrLigneSante Offers a Secure Communication Platform to Revolutionize Healthcare
A community of medical professionals sharing ideas and solving problems Lausanne, Switzerland (ots/PRNewswire) - LigneSante (https://lignesante.com/) today announced their online communication platform for healthcare professionals. The desire to connect to a collective knowledge around the management of diseases, aware that very often the complexity of medical ...
mehrThe list of speakers at the Zermatt Summit is impressive / 8th Zermatt Summit - September 12 - 14, 2019 in Zermatt
mehrDebiopharm and BIOASTER join forces to expand research to combat infectious diseases
Lausanne, Switzerland and Lyon, France (ots) - Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, and BIOASTER (www.bioaster.org), the French Technology Research Institute in infectiology and microbiology, announced today having officialized a broad research agreement for the development of diagnostic and management innovation for infectious diseases. ...
mehrNew sustainable business models are changing society, bringing hope and creating new jobs / 8th Zermatt Summit - 12th - 14th September 2019 in Zermatt
mehrIMD World Competitiveness Ranking: Singapore topples United States as world's most competitive economy
mehr